Since we have seen that combination therapy led to the expansion of functional CD8+ T cells in the tumor, we sought to determine if tumor suppression is indeed dependent on CD8+ T cells by depleting each immune cell type including CD4+ T, CD8+ T cells, and NK cells. The gene discussed is CD4; the disease is neoplasm.